LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Начало・Списък с акции・Thermo Fisher Scientific Inc
Search

Thermo Fisher Scientific Inc

Затворен

СекторЗдравеопазване

492.82 1.27

Силна покупка

Обновена цена 29.05.2026 г., 19:59 ч. UTC

КупиПродай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

491.57

Максимум

495.72

Ключови измерители

By Trading Economics

Приходи

-314M

1.7B

Продажби

-1.2B

11B

P/E

Средно за сектора

24.631

50.102

EPS

5.44

Дивидентна доходност

0.39

Марж на печалбата

15.048

Служители

125,000

EBITDA

-905M

2.3B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+25.87% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.39%

2.33%

Следващи печалби

22.07.2026 г.

Следваща дата на дивидент

15.07.2026 г.

Следваща дата на екс-дивидент

15.06.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-29B

167B

Предишно отваряне

491.55

Предишно затваряне

492.82

Настроения в новините

By Acuity

35%

65%

96 / 344 Класиране в Healthcare

Thermo Fisher Scientific Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.04.2026 г., 13:56 ч. UTC

Печалби

Thermo Fisher Profit Up, Warns of Inflation from Iran War -- Update

DJ

Прочетени

23.04.2026 г., 10:28 ч. UTC

Печалби

Thermo Fisher Posts Higher 1Q Profit, Revenue

DJ

Прочетени

29.01.2026 г., 11:34 ч. UTC

Печалби

Thermo Fisher 4Q Profit Rises as Biopharma Spending Rebounds

DJ

Прочетени

29.10.2025 г., 10:51 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 billion

DJ

Прочетени

23.10.2025 г., 20:49 ч. UTC

Печалби

Correction to Thermo Fisher Article on Oct. 22

DJ

Прочетени

22.10.2025 г., 10:28 ч. UTC

Печалби

Thermo Fisher 3Q Revenue Rises, Boosted by Life Sciences Business

DJ

Прочетени

15.05.2026 г., 10:45 ч. UTC

Пазарно говорене

Contract Drug Manufacturers to Benefit From U.S. Pharma Onshoring Push -- Market Talk

DJ

Прочетени

23.04.2026 г., 10:01 ч. UTC

Печалби

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

DJ

Прочетени

23.04.2026 г., 10:01 ч. UTC

Печалби

Thermo Fisher: Well Positioned to Deliver Strong Year >TMO

DJ

Прочетени

23.04.2026 г., 10:00 ч. UTC

Печалби

Thermo Fisher 1Q Net $1.65B >TMO

DJ

Прочетени

23.04.2026 г., 10:00 ч. UTC

Печалби

Thermo Fisher 1Q Adj EPS $5.44 >TMO

DJ

Прочетени

23.04.2026 г., 10:00 ч. UTC

Печалби

Thermo Fisher 1Q EPS $4.43 >TMO

DJ

Прочетени

23.04.2026 г., 10:00 ч. UTC

Печалби

Thermo Fisher 1Q Rev $11.01B >TMO

DJ

Прочетени

24.03.2026 г., 12:04 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher Completes Acquisition of Clario Holdings for $8.875 Billion >TMO

DJ

Прочетени

24.03.2026 г., 12:00 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher Scientific Completes Acquisition Of Clario Holdings, Inc. >TMO

DJ

Прочетени

29.01.2026 г., 11:01 ч. UTC

Печалби

Thermo Fisher 4Q Organic Revenue Rose 3% >TMO

DJ

Прочетени

29.01.2026 г., 11:00 ч. UTC

Печалби

Thermo Fisher: Entering 2026 From Position of Strength >TMO

DJ

Прочетени

29.01.2026 г., 11:00 ч. UTC

Печалби

Thermo Fisher 4Q Net $1.96B >TMO

DJ

Прочетени

29.01.2026 г., 11:00 ч. UTC

Печалби

Thermo Fisher 4Q Rev $12.22B >TMO

DJ

Прочетени

29.01.2026 г., 11:00 ч. UTC

Печалби

Thermo Fisher 4Q EPS $5.21 >TMO

DJ

Прочетени

29.01.2026 г., 11:00 ч. UTC

Печалби

Thermo Fisher 4Q Adj EPS $6.57 >TMO

DJ

Прочетени

29.10.2025 г., 10:06 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher: Clario Provides Endpoint Data Solutions for Clinical Trials >TMO

DJ

Прочетени

29.10.2025 г., 10:05 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher: Claro Deal Includes Potential Additional Earnout, Other Payments >TMO

DJ

Прочетени

29.10.2025 г., 10:05 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher to Buy Clario From Group Led by Astorg and Nordic Cap, Novo Holding, Cinven >TMO

DJ

Прочетени

29.10.2025 г., 10:04 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher Scientific to Pay $8.875 Billion at Closing for Clario Holdings >TMO

DJ

Прочетени

29.10.2025 г., 10:00 ч. UTC

Придобивния, сливания и поглъщания

Thermo Fisher Scientific to Acquire Clario Holdings >TMO

DJ

Прочетени

22.10.2025 г., 10:01 ч. UTC

Печалби

Thermo Fisher 3Q Organic Revenue Rose 3% >TMO

DJ

Прочетени

22.10.2025 г., 10:00 ч. UTC

Печалби

Thermo Fisher: In Great Position to Deliver on 2025 Objectives >TMO

DJ

Прочетени

22.10.2025 г., 10:00 ч. UTC

Печалби

Thermo Fisher 3Q Adj EPS $5.79 >TMO

DJ

Прочетени

22.10.2025 г., 10:00 ч. UTC

Печалби

Thermo Fisher 3Q Rev $11.12B >TMO

DJ

Прочетени

Сравнение с други в отрасъла

Ценова промяна

Thermo Fisher Scientific Inc Прогноза

Ценова цел

By TipRanks

25.87% нагоре

12-месечна прогноза

Среден 613.27 USD  25.87%

Висок 685 USD

Нисък 490 USD

Според 18 анализатори от Wall Street, предложили 12-месечна ценова цел за Thermo Fisher Scientific Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

18 ratings

16

Купи

2

Задържане

0

Продай

Според 18 анализатори, дали борсови рейтинги на Thermo Fisher Scientific Inc през последните 3 месеца.

Настроение

By Acuity

96 / 344 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar

Други акции от сектора

LLY

Eli Lilly and Co.

1,103

↓-2.23%

JNJ

Johnson and Johnson

225.18

↓-2.6%

ABBV

AbbVie Inc

217.96

↓-0.27%

UNH

UnitedHealth Group Inc

378.65

↓-0.98%

MRK

Merck & Co Inc.

118.6

↓-1.13%
help-icon Live chat